Showing results (71-80 of 352) with videos related to
Sort By:
Pageof 36
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Pulse wave analysis during instructed breathing as an indicator of significant coronary artery diseaseDavid Brosh, Abid Assali, Dan Greenberg, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 12, 2013
Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approachArieh Gavious, Dan Greenberg, Ariel Hammerman, et al.Harefuah|December 15, 2011
[Public financing for off-label use of drugs]Ariel Hammerman, Yoel Lipschitz, Joseph Pliskin, et al.Vaccine|February 15, 2018
Mass media effect on vaccines uptake during silent polio outbreakIftach Sagy, Victor Novack, Michael Gdalevich, et al.International Journal of Technology Assessment in Health Care|July 22, 2009
The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?Dan Greenberg, Miriam I Siebzehner, Joseph S PliskinInternational Journal of Cardiology|July 9, 2016
PCSK9 inhibitors may improve cardiovascular outcomes-Can we afford them?Ronen Arbel, Ariel Hammerman, Noa Triki, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2010
Does Medicare have an implicit cost-effectiveness threshold?James D Chambers, Peter J Neumann, Martin J BuxtonPharmacoeconomics|October 7, 2009
30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvementPeter J Neumann, Chi-Hui Fang, Joshua T CohenValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value FrameworksJoshua T Cohen, Jordan E Anderson, Peter J NeumannHealth Affairs (Project Hope)|September 13, 2006
Biotechnology and Medicare's new technology policy: lessons from three case studiesPatricia Seliger Keenan, Peter J Neumann, Kathryn A PhillipsPageof 36